RFA-HL-23-010 - Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Application Submission and Due Date Changes for RFA-HL-23-010, "Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)" NOT-HL-22-015 NHLBI Mar 24, 2022 Dec 21, 2024 R33

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)


Technical Issues: E-mail OER Webmaster